Quetiapine shortage ‘frankly unacceptable’ Some doses of the antipsychotic medication could be in shortage until July, leaving both patients and GPs ‘alarmed’.
‘Too little, too late’: An investigation into medication shortages How are medication shortages affecting GPs and their patients? Calls are being made to change how they are being managed and communicated.
Ozempic shortage extended The manufacturer has informed the TGA that supply will be limited until 31 December 2025, with GPs labelling it an ‘ongoing disappointment’.
‘Deeply concerns me’: Original prescriber’s alarm over cannabis trends Medicinal cannabis prescription rates are skyrocketing, with sales in the first half of 2024 almost equal to all of 2023 – but it comes amid mounting concern.
Medical devices impacted by 3G shutdown GPs are being urged to speak to their patients and take ‘necessary precautions’ as essential devices and alarms could be affected.
TGA rejects Alzheimer’s medication due to safety concerns Advocates say the decision not to register lecanemab is a missed opportunity to begin reversing impacts of Alzheimer’s disease.
TGA urges ‘extreme caution’ amid fake Ozempic pen imports GPs are being warned to lookout for the counterfeit pens and are urged to inform their patients, with one person already suffering life-threatening complications.
Admin burden top reason GPs plan to leave practice: RACGP In a ‘wakeup call’ for governments, the new Health of the Nation report found 70% of GPs are concerned about their admin workload.
‘Visionary’ review suggests quicker approval of new medicines New subsidised medication approvals would be streamlined and access made easier for vulnerable populations, under a new health technology plan.
Concern for rural practices as IV fluid shortage bites The TGA is working to find suitable alternatives, with the unprecedented shortage expected to last at least until the end of the year.